<DOC>
	<DOCNO>NCT00358345</DOCNO>
	<brief_summary>The primary objective study assess ability PreView PHP ( study device ) detect newly diagnose non-treated Choroidal Neovascularization ( CNV ) lesion associate advance Age-related Macular Degeneration ( AMD ) Myopia differentiate Intermediate AMD Geographic Atrophy ( GA ) patient high Myopia CNV . This study secondary enhance NotalVision normative database .</brief_summary>
	<brief_title>PreView PHP Preferential Hyperacuity Perimeter Detection Choroidal Neovascularization</brief_title>
	<detailed_description>- The study prospective , multi-center , comparative study . - A clinical trail FDA approval device ( 510K ) .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Newly diagnose ( yo 2 month ) CNV OR Intermediate AMD Age &gt; 50 AMD subject Age &gt; 18 Myopic subject VA 20/160 good study eye Mental physical ability perform PHP test Evidence macular disease AMD high myopia study eye . Previous surgical laser treatment within macular erea . Concurrent intraocular drug therapy ( within 30 day ) . Present significant medium opacity preclude clear veiw macula . Any non macular relate ocular surgery perform within 3 month prior study . CNV subject inability tolerate intravenous fluorscien angiography .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>AMD</keyword>
</DOC>